Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey

Table 1 Patient characteristics

Characteristic	SC HBIG, n = 29	IM HBIG, n = 15	IV HBIG, n = 46	Total, n = 90
Sex, n (%)
Male	22 (75.9)	10 (66.7)	33 (71.7)	65 (72.2)
Female	7 (24.1)	5 (33.3)	13 (28.3)	25 (27.8)
Age in years, mean ± SD	54.9 ± 10.7	49.4 ± 6.5	51.9 ± 11.2	52.5 ± 10.5
Country of residence, n (%)
France	18 (62.1)	0 (0)	12 (26.1)	30 (33.3)
Italy	11 (37.9)	15 (100)	22 (47.8)	48 (53.3)
Turkey	0 (0)	0 (0)	12 (26.1)	12 (13.3)
Duration on current HBIG treatment, n (%)
0 month	2 (6.9)	1 (6.7)	2 (4.4)	5 (5.6)
1-20 months	15 (51.7)	14 (93.3)	24 (53.3)	53 (59.6)
21-40 months	2 (6.9)	0 (0.0)	9 (20.0)	11 (12.4)
41-60 months	7 (24.1)	0 (0.0)	2 (4.4)	9 (10.1)
61 + months	3 (10.3)	0 (0.0)	8 (17.8)	11 (12.4)
mean ± SD	29.2 ± 28.8	8.9 ± 4.5	49.8 ± 80.2	36.2 ± 61.0
Marital status, n (%)
Single	0	0	3 (6.5)	3 (3.3)
Married/civil partnership	17 (58.6)	14 (93.3)	34 (73.9)	65 (72.2)
In a relationship	8 (27.6)	0	4 (9.0)	12 (13.3)
Separated/divorced	4 (13.8)	1 (6.7)	3 (6.5)	8 (8.9)
Other	0	0	1 (2.2)	1 (1.1)
Prefer not to answer	0	0	1 (2.2)	1 (1.1)
Living alone, n (%)	2 (6.9)	0	3 (6.5)	5 (5.6)
Occupation, n (%)
Employed full time	8 (27.6)	3 (20.0)	12 (26.1)	23 (25.6)
Employed part time	4 (13.8)	5 (33.3)	3 (6.5)	12 (13.3)
Not working	6 (20.7)	6 (40.0)	20 (43.5)	32 (35.6)
Retired	8 (27.6)	0	9 (19.6)	17 (18.9)
Other	3 (10.3)	1 (6.7)	2 (4.3)	6 (6.7)

HBIG: Hepatitis B immunoglobulin; IM: Intramuscular; IV: Intravenous; SC: Subcutaneous.